Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Venus Remedies Ltd (VENR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
318.90 -5.50    -1.70%
03/05 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE411B01019 
S/N:  VENUSREM
  • Volume: 25,684
  • Bid/Ask: 318.90 / 319.00
  • Day's Range: 316.85 - 327.30
Venus Remedies Ltd 318.90 -5.50 -1.70%

Venus Remedies Ltd Company Profile

 
Get an in-depth profile of Venus Remedies Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

942

Equity Type

ORD

Venus Remedies Limited engages in the development and marketing of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin care, wound management, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It is also involved in the provision of anti-infective, anticoagulant, and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Contact Information

Address Plot 51-52, Industrial Area Phase-1
Panchkula, 134113
India
Phone 91 17 2393 3090
Fax 91 17 2256 5566

Top Executives

Name Age Since Title
Manu Chaudhary 52 2006 Joint MD, Head of Research, Development & Operations and Whole-Time Director
Pawan Chaudhary 57 2009 Chairman, MD & CFO
Gilbert Wenzel 67 2006 Independent Non-Executive Director
Suresh Kumar Chadha 66 2006 Independent Non-Executive Director
Navdeep Sud 64 2020 Independent Non-Executive Director
Savita Gupta 50 - Independent Non-Executive Director
Peeyush Jain 51 - Deputy MD, Head of Indian Marketing Operations & Whole-Time Director
Akshansh Chaudhary 30 2021 CTO & Additional Whole Time Director
Ashutosh Jain 46 2007 CEO, Head of Legal, Regulatory Dept. & Whole-Time Director
NPS Monga 65 2023 Additional Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VENR Comments

Write your thoughts about Venus Remedies Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Saroj Sahu
Saroj Sahu May 05, 2020 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
excellent tool to analysis stock...
anil maurya
anil maurya Jan 17, 2017 7:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today 17 jan venus remidies breakout made a high of 105 short term target is 150 very fast hardly in 50 trading days
Mahesh Dwivedi
Mahesh Dwivedi Jan 17, 2017 7:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good Analysis
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email